PARP Inhibitors in Ovarian Cancer. Reply

N Engl J Med. 2020 Apr 16;382(16):1574-1575. doi: 10.1056/NEJMc2000644.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Ovarian Epithelial*
  • Female
  • Humans
  • Ovarian Neoplasms*
  • Poly(ADP-ribose) Polymerase Inhibitors

Substances

  • Poly(ADP-ribose) Polymerase Inhibitors